Tax Policies Related to Flower Industry - Agricultural producers selling flowers are exempt from value-added tax (VAT) [2] - Small-scale taxpayers can enjoy VAT exemption on flower sales if quarterly sales do not exceed 300,000 yuan; otherwise, VAT must be paid [3] - The VAT rate for fresh flowers is 9%, while processed flower products have a VAT rate of 13% [4] Corporate Income Tax Policies - Enterprises engaged in flower cultivation can benefit from a reduced corporate income tax rate [4] - Trading activities related to flowers do not qualify for the tax reduction [4] - Small and micro enterprises meeting specific criteria can have a corporate income tax burden as low as 5% until December 31, 2027 [4]

Group 1 - Li Ziqi's appearance at the 2025 CCTV Spring Festival Gala highlighted the popularity of peony porcelain accessories, which combine traditional craftsmanship with modern aesthetics [1] - The peony porcelain products, including rings, earrings, bracelets, and hair accessories, have become a popular representation of "Guochao" culture, appealing to younger consumers [1] - The production of peony porcelain reached nearly 70,000 pieces last year, showcasing the growth of this traditional craft [2] Group 2 - The peony porcelain gained international recognition as a "national gift" during the China-ASEAN Expo, featuring a stunning plate that symbolizes the beauty of Eastern aesthetics [2] - The development of peony pastries has evolved, with a new "pure peony" recipe achieved in 2023, enhancing the product's quality and appeal [3] - The extended product line of peony-related items, including paintings, pastries, and teas, has led to an annual output value exceeding 60 million yuan, demonstrating the economic potential of this industry [4]

Core Viewpoint - The company, Qing Song Co., Ltd., is primarily engaged in the design, research and development, and manufacturing of cosmetics, including facial masks, skincare products, and wet wipes, with a significant focus on ODM (Original Design Manufacturer) services [6][8]. Company Overview - The company operates in the chemical raw materials and chemical products manufacturing industry, specifically in the cosmetics manufacturing sector [6]. - The main business entity is its wholly-owned subsidiary, Nuo Si Bei Cosmetics Co., Ltd., which contributes 99.52% of the consolidated revenue [8]. Business Operations - Nuo Si Bei specializes in the design, research and development, and manufacturing of facial masks, skincare products, wet wipes, and non-woven fabric products, making it one of the largest domestic ODM companies in China [8]. - The upstream supply chain includes natural cellulose fibers, polyester fibers, and viscose fibers for mask substrates, while the downstream market consists of cosmetic brand owners and various retail channels, including e-commerce and physical stores [9]. Financial Data - The company has not restated or adjusted previous years' financial data, indicating stability in its financial reporting [10]. - The company has implemented a share repurchase plan, with a total repurchase amount of approximately RMB 65.8 million, representing 3.49% of the total share capital [11]. Major Projects - The company has decided to terminate the construction of a large industrial park project on 148 acres and is negotiating with government authorities to return the land use rights [12][13]. - A new investment partnership has been formed with Mi Jia Technology Co., Ltd. to develop the 148-acre land project, with Nuo Si Bei holding a 20% stake in the newly established joint venture [13][14]. Strategic Investments - The company has increased its stake in Guangdong Ke Pu Rui Biotechnology Co., Ltd. to 60%, enhancing its capabilities in synthetic biology and new material technology [15]. - A new wholly-owned subsidiary, Guangdong Nuo Mi Jia Biomedical Co., Ltd., has been established to support the company's strategic development needs [16].

一、主要会计数据和财务指标 前十大流通股东累计持有： 2472.09万股，累计占流通股比： 42%，较上期变化： -132.50万股。 | 名称 | 持有数量(万股) | 占总股本比例 | 增减情况(万 | | --- | --- | --- | --- | | | | (%) | 股) | | 曾本生 | 1398.46 | 23.76 | 不变 | | 上海辉盈投资合伙企业(有限合伙) | 353.96 | 6.01 | -29.44 | | 泉州市中和股权投资合伙企业(有限合伙) | 188.15 | 3.20 | 不变 | | 泉州嘉禾常兴股权投资合伙企业(有限合伙) | 117.77 | 2.00 | 不变 | | 宋燕 | 85.23 | 1.45 | 不变 | | 泉州宝荣商务咨询中心(有限合伙) | 76.10 | 1.29 | 不变 | | 黄鋆源 | 75.26 | 1.28 | 不变 | | 梁关飞 | 60.10 | 1.02 | -11.65 | | 韩汉明 | 59.97 | 1.02 | 新进 | | 交通银行股份有限公司-博时新兴成长混合型证券投 资基金 | 57.09 | 0 ...

嘉亨家化（300955）公告，2024年营业收入9.23亿元，同比下降9.13%。归属于上市公司股东的净利 润-2369.7万元，同比下降159.00%。公司拟向全体股东每10股派发现金红利2.8元(含税)，送红股0股(含 税)，以资本公积金向全体股东每10股转增0股。 ...

据 IPO早知道消息，江苏正力新能电池技术股份有限公司（以下简称"正力新能"） 于 4月3日开启 招股、至 4月9日结束，并计划于2025年4月14日正式以"3677"为股票代码在港交所主板挂牌上 市。 正力新能计划在本次 IPO中发行121,523,700股H股，其中香港公开发售12,152,400股H股，国际 发售109,371,300股H股。 在本次 IPO发行中，正力新能共引入三名基石投资者，累计认购规模7990万美元（约6.21亿港元） ——其中，江苏国企混改基金和苏州高端装备基金分别认购1350万美元和2760万美元，现有股东东 南投控认购3880万美元。 以每股 8.27港元的发行价计算，正力新能的IPO市值将为207.45亿港元。 一周IPO动态，覆盖港股、美股、A股。 本文为IPO早知道原创 作者｜C叔 微信公众号｜ipozaozhidao 正力新能 港股｜开启招股 成立于 2019年的正力新能专注于动力电池产品和储能电池产品，可提供电芯、模组、电池包、电池 簇、电池管理系统的一体化方案，致力于拓展电化学产品的 大规模应用。目前，正力新能已开发多 款三元、磷酸铁锂电池产品，在中期来看，不断优 ...

Core Viewpoint - Gu Yu Biotechnology Group Co., Ltd. has initiated its IPO process, marking a significant step in its growth trajectory within the beauty industry, leveraging unique product offerings and a strong online presence to capture market share [1][2][3]. Company Overview - Gu Yu was founded on March 24, 2010, with a registered capital of 36 million RMB, and is headquartered in Guangzhou [1]. - The company is primarily engaged in the manufacturing of cosmetics, specifically focusing on skincare products with unique ingredients like Glabridin [1][3]. - The founder, Wang Anning, has extensive experience in the cosmetics industry, having worked in his family's supply chain and developed numerous formulations before establishing Gu Yu [3][6]. IPO Progress - Gu Yu has signed a counseling agreement with CITIC Securities on March 27, 2025, to prepare for its IPO, officially starting the process for listing on the A-share market [1][10]. - The company has undergone a name change and shareholding restructuring in early 2024, indicating readiness for public offering [7][10]. Market Position and Performance - Despite being a latecomer compared to established brands like Proya and Han Shu, Gu Yu has rapidly gained recognition, ranking third in the Douyin beauty category in early 2023 [2][11]. - The brand's GMV (Gross Merchandise Volume) has shown significant growth, reaching 9 billion RMB in 2021, doubling to 22 billion RMB in 2022, and projected to reach 35 billion RMB in 2023 [11][13]. - Gu Yu's sales strategy focuses on multi-channel distribution, successfully leveraging platforms like Douyin, Kuaishou, and Tmall to maximize reach and sales [11][21]. Product Strategy - The company has developed a product matrix centered around its unique ingredient, Glabridin, with a focus on "big single products + gift sets" [23][24]. - Gu Yu's best-selling products include the third-generation snow skin water and cream sets, which have sold over 125,800 units [23]. Challenges and Future Outlook - Gu Yu faces challenges related to high dependency on a single brand for revenue, which poses risks compared to competitors with diversified brand portfolios [26][27]. - The company is also navigating the complexities of high-end market positioning, as it attempts to penetrate the premium segment while maintaining its value-oriented brand image [32][34]. - The ongoing development of its research capabilities and potential expansion into offline channels will be crucial for sustaining growth and competitiveness in the evolving beauty market [34][41].

入大、新旧产业融合存在不确定性、尚处于成长期、经营风险高、业绩不稳定、 退市风险高等特点，投资者面临较大的市场风险。投资者应充分了解创业板的投 资风险及本公司所披露的风险因素，审慎作出投资决定。 哈尔滨敷尔佳科技股份有限公司 （哈尔滨市松北区美谷路 500 号） 首次公开发行股票并在创业板上市 招股说明书 保荐人（主承销商） 广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座 创业板投资者风险提示：本次发行股票拟在创业板上市，创业板公司具有创新投 哈尔滨敷尔佳科技股份有限公司 首次公开发行股票并在创业板上市招股说明书 声 明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担 股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1 哈尔滨敷尔佳科技股份有 ...

创业板投资者风险提示：本次发行股票拟在创业板上市，创业板公司具有创新投 入大、新旧产业融合存在不确定性、尚处于成长期、经营风险高、业绩不稳定、 退市风险高等特点，投资者面临较大的市场风险。投资者应充分了解创业板的投 资风险及本公司所披露的风险因素，审慎作出投资决定。 哈尔滨敷尔佳科技股份有限公司 （哈尔滨市松北区美谷路 500 号） 首次公开发行股票并在创业板上市 招股意向书 保荐人（主承销商） 广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座 哈尔滨敷尔佳科技股份有限公司 首次公开发行股票并在创业板上市招股意向书 声 明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担 股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 哈尔滨敷尔佳科 ...

证券简称：芭薇股份 证券代码：837023 广东芭薇生物科技股份有限公司 广东省广州市白云区新贝路 5 号 广东芭薇生物科技股份有限公司招股说明书（申报稿） 本公司的发行申请尚未经中国证监会注册。本招股说明书申报稿不具有据以发行 股票的法律效力，投资者应当以正式公告的招股说明书全文作为投资决定的依据。 本次股票发行后拟在北京证券交易所上市，该市场具有较高的投资风险。北京证 券交易所主要服务创新型中小企业，上市公司具有经营风险高、业绩不稳定、退市风 险高等特点，投资者面临较大的市场风险。投资者应充分了解北京证券交易所市场的 投资风险及本公司所披露的风险因素，审慎作出投资决定。 保荐机构（主承销商） （广州市天河区珠江东路 11 号 18、19 楼全层） 中国证监会和北京证券交易所对本次发行所作的任何决定或意见，均不表明其对 注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其对发行 人的盈利能力、投资价值或者对投资者的收益作出实质性判断或者保证。任何与之相 反的声明均属虚假不实陈述。 根据《证券法》的规定，股票依法发行后，发行人经营与收益的变化，由发行人 自行负责；投资者自主判断发行人的投资价值 ...